Mitochondria | CHOP Research Institute
 

Mitochondria

Dr. Festa works to understand the molecular mechanisms underpinning normal neurodevelopment with a specific focus on white matter. She also focuses on discovering new therapeutic targets to restore or prevent white matter injury across a number of different pediatric neurologic conditions.

E-mail:
festal1 [at] chop.edu
Published on
Nov 5, 2025
Targeting the mitochondria improved blood-brain barrier function and cognition in a preclinical model of the genetic disorder.
Published on
Jun 3, 2024
The CHOP-Penn Autism Research Symposium explored opportunities for breakthroughs in the understanding and treatment of autism spectrum disorder.
Published on
Nov 16, 2023
The Connor Initiative, a multimillion dollar gift from the Holveck Family, will support precision therapeutics for osteosarcoma and rare cancers.
Published on
Nov 13, 2023
Douglas C. Wallace, PhD, investigates the role of adaptive immunity in the etiology of Alzheimer’s disease (AD) and AD-related dementias.
Published on
Oct 13, 2023
In our weekly news roundup, Dr. Beverly Davidson received a $1 million grant to study Huntington’s disease. This and more on Cornerstone.
Published on
Sep 29, 2023
This week’s In The News reports on higher education vaccination policies, college athletes’ concussions, a new genetic disease, and zebrafish.
Published on
Aug 18, 2023
The FDA approved an oral drug, based on foundational research conducted at CHOP, to treat a rare, severe bone disease. More In The News.
Published on
Mar 2, 2023
With a grant from the Gates Foundation, CHOP researchers are working to determine the importance of mitochondria DNA variation in COVID-19 severity.
Published on
Apr 1, 2022
Learn about earn about a regional research collaboration, prestigious awards, and listen to a special podcast series.